. 2018 Feb 13;9(3):262–267. doi: 10.1021/acsmedchemlett.8b00003

Table 2. Antiproliferative Effects against Prostate Cell Lines C4-2B, LNCaP, 22Rv1, PC3, and Du145.

	cell growth inhibition (IC₅₀, μM)^a
compd	C4-2B	LNCaP	22Rv1	PC-3	Du145
1	0.19	0.16	0.071	3.01	2.52
15	7.04	8.40	8.02	30.40	35.93
17	13.26	7.52	13.08	40.13	92.56
23	7.16	7.80	7.05	26.95	54.50
25	6.56	6.28	4.85	21.01	30.93
36	3.23	4.41	3.38	17.22	23.19
37	7.75	7.70	7.59	22.85	33.24

The IC₅₀ was calculated from cell viability assay by Cell-Titer GLO (Promega).